{
    "clinical_study": {
        "@rank": "45426", 
        "brief_summary": {
            "textblock": "This study tests the safety and effectiveness of a flu vaccine in school children.\n\n      School children are usually the first members of a community to come down with the flu, and\n      they often give the flu to their younger siblings, parents, and grandparents.  It is hoped\n      that giving school children a flu vaccine can help prevent the spread of the flu to other\n      members of the community."
        }, 
        "brief_title": "Study of a Flu Vaccine in Children", 
        "completion_date": "November 2005", 
        "condition": "Influenza", 
        "condition_browse": {
            "mesh_term": "Influenza, Human"
        }, 
        "detailed_description": {
            "textblock": "This is a Phase III trial (an advanced study with a large number of patients).  Your child\n      will receive a single dose of flu vaccine, which is given by a nasal spray."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Your child may be eligible for this study if he/she:\n\n          -  Is between the ages of 18 months and 18 years, with consent of parent or guardian.\n\n          -  Is a resident of the Temple-Belton, Texas area.\n\n        Exclusion Criteria:\n\n        Your child will not be eligible for this study if he/she:\n\n          -  Has had a fever within 3 days before vaccination.\n\n          -  Has symptoms of a weakened immune system.\n\n          -  Has had a wheezing episode within the past 2 weeks.\n\n          -  Has moderate to severe asthma.\n\n          -  Is allergic to eggs.\n\n          -  Needs to take aspirin on a regular basis.\n\n          -  Has received another vaccine or study drug in the past month."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "18 Years", 
            "minimum_age": "18 Months"
        }, 
        "enrollment": "15000", 
        "firstreceived_date": "January 17, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001127", 
            "org_study_id": "DMID 99-021", 
            "secondary_id": "AV012"
        }, 
        "intervention": {
            "intervention_name": "Influenza virus vaccine (CAIV-T)", 
            "intervention_type": "Biological"
        }, 
        "lastchanged_date": "August 26, 2010", 
        "location": {
            "facility": {
                "address": {
                    "city": "Houston", 
                    "country": "United States", 
                    "state": "Texas", 
                    "zip": "77030"
                }, 
                "name": "Pedro A. Piedra, M.D."
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Study of the Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (CAIV-T) in a Community-Based, Non-Randomized, Open-Label Trial in Children to Assess Safety and Herd Immunity for the Control of Epidemic Influenza", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001127"
        }, 
        "source": "National Institute of Allergy and Infectious Diseases (NIAID)", 
        "sponsors": {
            "collaborator": {
                "agency": "Aviron", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "National Institute of Allergy and Infectious Diseases (NIAID)", 
                "agency_class": "NIH"
            }
        }, 
        "study_design": "Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "November 2005"
    }, 
    "geocoordinates": {
        "Pedro A. Piedra, M.D.": "29.76 -95.369"
    }
}